Low risk for CRC with dysplasia resection in IBD patients

After dysplasia resection in patients with inflammatory bowel disease, risk for colorectal cancer was low, according to results published in Gastrointestinal Endoscopy.“This is a novel finding of this study and seems to support the hypothesis that tumor progression in inflammatory bowel segment does not always follow the [low-grade dysplasia (LGD)] to [high-grade dysplasia (HGD)] to cancer pathway,” Babu P. Mohan, MD, from the department of gastroenterology and hepatology at the University of Utah Health, and colleague wrote. “The failure to achieve statistical significanceRead More

Share on facebook
Share on twitter
Share on linkedin